Radial optic neurotomy for central retinal vein occlusion: Results of the pan-american collaborative retina study group (pacores)
OBJECTIVE: To evaluate the complications after radial optic neurotomy (RON) for central retinal vein occlusion (CRVO). METHODS: Seventy-three consecutive patients (73 eyes) with CRVO who were treated with RON participated in a retrospective, uncontrolled, interventional, multicenter case series at 7...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2008
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22936
- Acceso en línea:
- https://doi.org/10.1097/IAE.0b013e3181744153
https://repository.urosario.edu.co/handle/10336/22936
- Palabra clave:
- Adult
Aged
Anterior eye segment
Artery perforation
Article
Case study
Cataract
Central retina vein occlusion
Controlled study
Cryotherapy
Disease severity
Female
Glaucoma drainage implant
Human
Laser coagulation
Lens implantation
Major clinical study
Male
Neovascular glaucoma
Neovascularization (pathology)
Optic nerve atrophy
Phacoemulsification
Postoperative complication
Radial optic neurotomy
Retina detachment
Retina macula edema
Retrospective study
Treatment outcome
Visual acuity
Vitrectomy
Vitreous hemorrhage
Clinical trial
Hospitalization
Incidence
Methodology
Middle aged
Multicenter study
Neurosurgery
Pathophysiology
Postoperative complication
Retina vein occlusion
Adult
Aged
Female
Humans
Incidence
Male
Middle aged
Neurosurgical procedures
Postoperative complications
Retinal vein occlusion
Retrospective studies
Severity of illness index
Treatment outcome
Visual acuity
Central retinal vein occlusion
Complications
Radial optic neurotomy
- Rights
- License
- Abierto (Texto Completo)
Summary: | OBJECTIVE: To evaluate the complications after radial optic neurotomy (RON) for central retinal vein occlusion (CRVO). METHODS: Seventy-three consecutive patients (73 eyes) with CRVO who were treated with RON participated in a retrospective, uncontrolled, interventional, multicenter case series at 7 institutions from 6 countries. RESULTS: In the ischemic CRVO group (n = 53), 32% of eyes had an improvement in best-corrected visual acuity (BCVA) (mean, 5.5 lines), 35.8% had worse BCVA (mean, 6.4 lines), and 32% had BCVA that remained the same after RON. In the nonischemic CRVO group (n = 20), 50% of eyes had an improvement in BCVA (mean, 6.5 lines), 15% had worse BCVA (mean, 4.3 lines), and 35% had BCVA that remained the same after RON. Complications occurred in 71.2% of cases, including cataract in 17 eyes (23.2%), vitreous hemorrhage in 16 eyes (20.5%), persistent macular edema in 15 eyes (20.5%), neovascular glaucoma in 7 eyes (9.5%), anterior segment neovascularization in 5 eyes (6.8%), retinal detachment in 3 eyes (4.1%), and phthisis bulbi, choroidovitreal neovascularization, central retinal artery perforation, and optic nerve atrophy in 1 eye (1.3%) each. CONCLUSIONS: RON may improve visual acuity in some eyes with CRVO, but complications are common. In our series, surgery by itself did not seem to improve the outcome of CRVO when compared with its natural history. Copyright © 2008 by the Ophthalmic Communication Society Inc. |
---|